Dossier
high-risk patients
Coverage of high-risk patients in the Nexus archive.
- FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients
The FDA has approved Lipfendra, a first-of-its-kind pill by Merck, to significantly reduce cholesterol in high-risk patients. This oral medication offers a cost-effective alternative to previously available expensive injectable treatments for lowering dangerous cholesterol levels.